Scienture Holdings (SCNX) Return on Sales by Net Profit

Scienture Holdings - graphic logo of issuer SCNX

Scienture Holdings Inc (SCNX) revenues rely on the demand for modified drugs and the speed of regulatory approvals. The net profit margin shows a metric value of -3145.80, which helps assess the actual profit from revenue. Scienture Holdings Inc (SCNX) is developing AI platforms for drug modeling, while stability is ensured by long-term agreements with medical centers and the management of patent risks.

Scienture Holdings Inc (SCNX) - Net Profit Rate from 09/24/2024 to 11/20/2026

Financial and market metric breakdowns for Scienture Holdings Inc. (SCNX)

- share price and expert price forecast:
Summary company analysis:Scienture Holdings - SCNX
Manufactured product of Scienture Holdings

Sales margin measures the efficiency of converting revenue into net profit after deducting all operating and financial expenses. This ratio determines the share of free capital available for development or dividend payments. The current net profit margin is -3145.80, reflecting the final profitability of the business. The dynamics of this value are critical for Scienture Holdings Inc (SCNX), as the costs of complying with the digital sovereignty of different countries can significantly reduce profitability. Geopolitical restrictions on data exchange directly limit the scaling of the IT platform, creating risks for the margin.

Competitors of Scienture Holdings Inc (SCNX)

Veeva Systems (VEEV) - Net Margin|Doximity - Net Profit Rate|Return on Sales by Net Profit HQY|Net Margin WAY|Net Margin CorVel Healthcare (CRVL)|Net Margin PRVA (Privia Health)|Net Margin Huron HURN|Company Sales Margin Certara (CERT)|OMCL: Return on Sales by Net Profit|GDRX (GoodRx Corp) - Net Return on Sales|Schrödinger (SDGR) - Net Margin|phreesia.com - Net Profit Rate|Net Margin Omada Health Corp|Evolent Health Inc (EVH) - Company Sales Margin|Net Sales Margin HSTM|Return on Sales by Net Profit Definitive Healthcare Inc. DH|Net Margin consensus.com CCSI|Company Net Profitability AGL (agilon health)|ABSI - Net Margin|SY (So-Young International Inc.) - Net Return on Sales|NRC: Net Sales Margin|SPOK - Company Sales Margin|OPRX (optimizerx.com) - Net Sales Margin|TBRG (TruBridge) - Company Net Profitability|Net Margin Simulations Plus Inc (SLP)|SOPH: Net Profit Margin|Net Sales Margin HCAT (Health Catalyst Inc)|CCLD - Return on Sales by Net Profit|researchsolutions.com - Net Sales Margin|Company Sales Margin DLH Corp DLHC|OneMedNet Corp. (ONMD) - Net Margin|HCTI - Company Sales Margin|ISPC (iSpecimen) - Net Sales Margin|Bullfrog AI (BFRG) - Company Sales Margin|Net Margin SCWorx Corp (WORX)|msprecovery.com - Net Return on Sales|Net Sales Margin ICCT (icoreconnect.com)|TRxADE HEALTH (MEDS) - Net Margin|orgenesis.com - Net Sales Margin|R1 RCM, Inc. (RCM) - Return on Sales by Net Profit|SHCR: Net Sales Margin|STRM: Company Net Profitability|Net Margin Syra Health|AMEH: Net Profit Rate|Net Sales Margin MODN|NextGen Healthcare - Net Return on Sales